177Lu-RAYZ-8009

N/A

Report date: 2026/04/17 20:02:02
NME

Base Information

Drug Name177Lu-RAYZ-8009
Drug Alias Name[177Lu]Lu-RYZ-GPC3177Lu-RAYZ-8009177Lu RAYZ-8009177LuRAYZ-8009DOTA-RYZ-GPC3
ClassificationRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionGlypican-3 binders
TargetsGlypican-3
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPeptiDream IncRayzeBio Inc
China Registration ClassN/A

Develop Information

Active CompaniesPeptiDream IncRayzeBio Inc
Inactive CompaniesN/A
Active IndicationsCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A